Ustekinumab for the treatment of adults with moderate to severe psoriasis

Technology appraisal guidance
Reference number: TA180
Published: 23 September 2009
Last updated: 03 March 2017

Appendix A: Decision paper presented to the Institute's Guidance Executive

Appendix A: Decision paper presented to the Institute's Guidance Executive

Appendix A: Decision paper presented to the Institute's Guidance Executive
30 September 2010
(105.15 Kb 30 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 30 September 2010